MAB

(redirected from monoclonal antibody)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

MAB

Master Air Waybill

A document describing goods to be transported by multiple airlines, usually internationally. The first airline issues a waybill to prove that the goods have been received and are ready for transport.
Mentioned in ?
References in periodicals archive ?
The European researchers gave half of the patients a daily intravenous infusion of the monoclonal antibody for 6 days.
Bigpharma not active in cancer monoclonal antibody partnering
Chapter 6 - Future trends and companies in cancer monoclonal antibody deal making
4 Top 5 Domestic Monoclonal Antibody Manufacture Enterprises in China
In Cancer Monoclonal Antibody Partnering Agreements, the available deals are listed by: Company A-Z Headline value Stage of development at signing Deal component type Specific oncology therapy target Monoclonal antibody type Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Comprehensive analysis of the monoclonal antibody therapeutics market
Propelled by the optimistic market prospect, advancement of monoclonal antibody technologies and the upcoming patent expiration of several key monoclonal antibody agents, the research and industrialization of monoclonal antibody agents has become a global investment highlight, wherein the future market competition will be evident.
This report assesses the overall monoclonal antibody market, as part of the wider protein therapeutics industry.
The initial chapters of this report provide an orientation of cancer monoclonal antibody dealmaking and business activities.
SGN-33 (lintuzumab) is a humanized monoclonal antibody that targets the CD33 antigen.
The lifecycle of monoclonal antibody therapies are longer because of the lack of biosimilar competition

Full browser ?